![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/FREDUN.png)
Share the post "Fredun Pharmaceuticals Shareholding pattern FY(Q3-Dec 2024-2025)"
Shareholding results capture the distribution of ownership in a company as outlined in its financial disclosures. These results indicate the proportion of shares held by different investor categories and can reveal trends in market confidence. By studying shareholding results, investors and analysts can assess the influence of major shareholders on corporate governance and stock price movements. Fredun Pharmaceuticals has released its latest shareholding reports, covering the third quarter and the fiscal year ending on (Q3-Dec 2024-2025).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
| Shareholder Name | Previous Quarter Quantity | Current Quarter Quantity | Previous Quarter Shares(in %) | Current Quarter Shares(in %) | Quarter to Quarter Difference |
|---|---|---|---|---|---|
| Promoters | 23.10 Lakh | 23.10 Lakh | 48.93 | 48.93 | 0 |
| Public | 24.11 Lakh | 24.11 Lakh | 49.48 | 49.48 | 0 |
| DII | 75.00 K | 75.00 K | 1.59 | 1.59 | 0 |
| FII | 0 | 0 | 0 | 0 | 0 |
| Government | 0 | 0 | 0 | 0 | 0 |
Promoters shareholding remained stable, at 48.93% in both September 2024- and December 2024-. This indicates that the promoters’ control over the company did not change during this period. Public shareholding remained consistent, holding steady at 49.48% in both September 2024- and December 2024-. This indicates that the Public control over the company did not change during this period. DIIs (Domestic Institutional Investors) shareholding remained unchanged at 1.59% from September 2024- to December 2024-. This indicates that domestic institutions maintained their investment level in the company.
Below is a detailed table showcasing the public shareholding percentage.
| Shareholder Name | Previous Quarter Quantity | Current Quarter Quantity | Previous Quarter Shares (in %) | Current Quarter Shares (in %) | Quarter-to-Quarter Difference (%) |
|---|---|---|---|---|---|
| Resident Individuals holding nominal share capital up to Rs. 2 lakhs | 15.87 Lakh | 16.04 Lakh | 33.61 | 33.97 | + 0.36 % |
| Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs | 5.00 Lakh | 5.00 Lakh | 10.6 | 10.58 | -0.02 % |
| ARUN KUMAR MUKHERJEE | 67.47 K | 48.73 K | 1.43 | 1.03 | -0.4 % |
| Non Resident Indians (NRIs) | 1.04 Lakh | 91.80 K | 2.19 | 1.94 | -0.25 % |
| Bodies Corporate | 32.75 K | 28.55 K | 0.69 | 0.6 | -0.09 % |
| HUF | 86.11 K | 88.99 K | 1.82 | 1.88 | + 0.06 % |
| LLP | 22.53 K | 19.46 K | 0.48 | 0.41 | -0.07 % |
Leading the way to higher stakeholding, Resident Individuals holding nominal share capital up to Rs. 2 lakhs has significantly boosted stakeholding by an impressive 0.36 %.Observations show a significant difference of -0.02 % in Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs’s financial performance between quarters.Observations show a significant difference of -0.4 % in ARUN KUMAR MUKHERJEE’s financial performance between quarters.Observations show a significant difference of -0.25 % in Non Resident Indians (NRIs)’s financial performance between quarters.Observations show a significant difference of -0.09 % in Bodies Corporate’s financial performance between quarters.Leading the way to higher stakeholding, HUF has significantly boosted stakeholding by an impressive 0.06 %.Observations show a significant difference of -0.07 % in LLP’s financial performance between quarters.
Nikhil Kishorchandra Vora, these shareholders are the Anchor investors of current and previous quarter. [my_shortcode1 values=”Fredun Pharmaceuticals”]
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/ICICIPRULI.png)
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/DIAMANT.png)
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/OTCO.png)